KIDS (OrthoPediatrics) Interest Expense : $-3.1 Mil (TTM As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is OrthoPediatrics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. OrthoPediatrics's interest expense for the three months ended in Mar. 2025 was $ -1.1 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2025 was $-3.1 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. OrthoPediatrics's Operating Income for the three months ended in Mar. 2025 was $ -10.9 Mil. OrthoPediatrics's Interest Expense for the three months ended in Mar. 2025 was $ -1.1 Mil. OrthoPediatrics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

OrthoPediatrics Interest Expense Historical Data

The historical data trend for OrthoPediatrics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrthoPediatrics Interest Expense Chart

OrthoPediatrics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-3.41

-2.25

-2.42

-2.62

OrthoPediatrics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Interest Expense	Get a 7-Day Free Trial															-0.64	-0.26	-0.40	-1.32	-1.13

OrthoPediatrics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.1 Mil.

OrthoPediatrics (NAS:KIDS) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

OrthoPediatrics's Interest Expense for the three months ended in Mar. 2025 was $-1.1 Mil. Its Operating Income for the three months ended in Mar. 2025 was $-10.9 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2025 was $73.0 Mil.

OrthoPediatrics's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

OrthoPediatrics did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

OrthoPediatrics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OrthoPediatrics Corp (NAS:KIDS) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

2X7:Germany

Address

2850 Frontier Drive, Warsaw, IN, USA, 46582

Website

https://www.orthopediatrics.com

OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.

Executives

Joseph W Hauser	officer: Sr VP & GM Trauma & Deformity	6428 RIDGELINE DR, HUDSON OH 44236
Fred Hite	director, officer: Chief Financial Officer	ORTHOPEDIATRICS, 2850 FRONTIER DR., WARSAW IN 46582
Daniel J Gerritzen	officer: General Counsel and Secretary	2850 FRONTIER DRIVE, WARSAW IN 46582
David R Bailey	officer: Executive Vice President	2850 FRONTIER DRIVE, WARSAW IN 46582
Gregory A Odle	officer: Executive Vice President	2850 FRONTIER DRIVE, WARSAW IN 46582
Mark C Throdahl	director, officer: President and CEO	ORTHOPEDIATRICS, 2850 FRONTER DR., WARSAW IN 46582
Terry D Schlotterback	director	2850 FRONTIER DRIVE, WARSAW IN 46582
Dyer George Sinclair Mitchell	director	55 ORCHARD ST., CAMBRIDGE MA 02140
Jimmy Duane Mcdonald	director	28662 N. 71ST STREET, SCOTTSDALE AZ 85226
David R Pelizzon	director, 10 percent owner	2850 FRONTIER DR, WARSAW IN 46582
Squadron Capital Holdings Llc	10 percent owner	18 HARTFORD AVENUE, PO BOX 223, GRANBY CT 06053
Squadron Capital Llc	10 percent owner	2850 FRONTIER DR., WARSAW IN 46582
Harold Ruf	director	2850 FRONTIER DR, WARSAW IN 46582
Jennifer N. Pritzker	10 percent owner	C/O SQUADRON CAPITAL LLC, 104 S. MICHIGAN AVENUE, SUITE 500, CHICAGO IL 60603
Infante (reynolds) Marie C	director	2850 FRONTIER DR, WARSAW IN 46582